FY2026 EPS Estimates for Tourmaline Bio Lowered by Analyst
Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) – Investment analysts at Leerink Partnrs dropped their FY2026 earnings per share (EPS) estimates for shares of Tourmaline Bio in a research report issued to clients and investors on Wednesday, May 21st. Leerink Partnrs analyst T. Smith now expects that the company will earn ($4.45) per share for […]
